Neutral impactCorporate Action
Eris Lifesciences Limited — Alteration Of Capital and Fund Raising-XBRL
NSE 26 Jun·26 Jun 2026, 9:47 am
Eris LifesciencesEris Lifesciences limited has informed the Exchange regarding Allotment of Securities
Affected stocks
Neutral1 stockBull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Eris Lifesciences (ERIS).
- Category: Corporate Action.
Why it matters
A routine update for Eris Lifesciences. Use the price and stock snapshot to gauge how the market is responding.
